Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A multi-state model of chemoresistance to characterize phenotypic dynamics in breast cancer
Grant Howard, Kaitlyn E. Johnson, Areli Rodriguez Ayala, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells
Sarthak Sahoo, Ashutosh Mishra, Harsimran Kaur, et al.
NAR Cancer (2021) Vol. 3, Iss. 3
Open Access | Times Cited: 66
LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway
Ming Zhang, Yan Wang, Longyang Jiang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 43
Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancer
Sarah M. Groves, Geena V. Ildefonso, Caitlin O. McAtee, et al.
Cell Systems (2022) Vol. 13, Iss. 9, pp. 690-710.e17
Open Access | Times Cited: 34
Interplay of Darwinian Selection, Lamarckian Induction and Microvesicle Transfer on Drug Resistance in Cancer
Arturo Álvarez-Arenas, Ana Podolski-Renić, Juan Belmonte-Beitia, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 47
LINC00160 mediated paclitaxel‐And doxorubicin‐resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ
Huaiguo Wu, Juan Gu, Daoping Zhou, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 15, pp. 8589-8602
Open Access | Times Cited: 43
Quantification of long-term doxorubicin response dynamics in breast cancer cell lines to direct treatment schedules
Grant Howard, Tyler A. Jost, Thomas E. Yankeelov, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 3, pp. e1009104-e1009104
Open Access | Times Cited: 25
Cytotoxic and chemomodulatory effects of Phyllanthus niruri in MCF-7 and MCF-7ADR breast cancer cells
Ola E. Abdel-Sattar, Rasha M. Allam, Ahmed M. Al‐Abd, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models
Nourhan M. Abdelmaksoud, Ahmed I. Abulsoud, Ahmed S. Doghish, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188993-188993
Closed Access | Times Cited: 15
Drug tolerance and persistence in bacteria, fungi and cancer cells: Role of non-genetic heterogeneity
Imane El Meouche, Paras Jain, Mohit Kumar Jolly, et al.
Translational Oncology (2024) Vol. 49, pp. 102069-102069
Closed Access | Times Cited: 5
Computational identification of surface markers for isolating distinct subpopulations from heterogeneous cancer cell populations
Andrea Gardner, Tyler A. Jost, Daylin Morgan, et al.
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Integrating transcriptomics and bulk time course data into a mathematical framework to describe and predict therapeutic resistance in cancer
Kaitlyn E. Johnson, Grant Howard, Daylin Morgan, et al.
Physical Biology (2020) Vol. 18, Iss. 1, pp. 016001-016001
Open Access | Times Cited: 27
Cancer Hallmarks Define a Continuum of Plastic Cell States between Small Cell Lung Cancer Archetypes
Sarah M. Groves, Abbie S. Ireland, Qi Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 16
Mathematical characterization of population dynamics in breast cancer cells treated with doxorubicin
Emily Y. Yang, Grant Howard, Amy Brock, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 12
Phototoxic effectiveness of zinc phthalocyanine tetrasulfonic acid on MCF-7 cells with overexpressed P-glycoprotein
Aniogo Eric Chekwube, Blassan P. George, Heidi Abrahamse
Journal of Photochemistry and Photobiology B Biology (2020) Vol. 204, pp. 111811-111811
Closed Access | Times Cited: 17
Computational identification of surface markers for isolating distinct subpopulations from heterogeneous cancer cell populations
Andrea Gardner, Tyler A. Jost, Amy Brock
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part II
Jakub Witkowski, Sebastian Polak, Z. Rogulski, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11939-11939
Open Access | Times Cited: 7
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part I
Jakub Witkowski, Sebastian Polak, Z. Rogulski, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12984-12984
Open Access | Times Cited: 7
A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells
Sarthak Sahoo, Ashutosh Mishra, Harsimran Kaur, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Integrating multimodal data sets into a mathematical framework to describe and predict therapeutic resistance in cancer
Kaitlyn E. Johnson, Grant Howard, Daylin Morgan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 8
Multi‑drug‑resistance efflux in cisplatin‑naive and cisplatin‑exposed A2780 ovarian cancer cells responds differently to cell culture dimensionality
Vasilij Koshkin, Mariana De Oliveira, Chun Peng, et al.
Molecular and Clinical Oncology (2021) Vol. 15, Iss. 2
Open Access | Times Cited: 8
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part III
Jakub Witkowski, Sebastian Polak, Dariusz Pawelec, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2239-2239
Open Access | Times Cited: 3
Spheroid-Based Approach to Assess the Tissue Relevance of Analysis of Dispersed-Settled Tissue Cells by Cytometry of the Reaction Rate Constant
Vasilij Koshkin, Mariana Bleker de Oliveira, Chun Peng, et al.
Analytical Chemistry (2020) Vol. 92, Iss. 13, pp. 9348-9355
Closed Access | Times Cited: 6
Cell Population Growth Kinetics in the Presence of Stochastic Heterogeneity of Cell Phenotype
Yue Wang, Joseph Zhou, Edoardo Pedrini, et al.
arXiv (Cornell University) (2023)
Open Access | Times Cited: 2
Cell population growth kinetics in the presence of stochastic heterogeneity of cell phenotype
Yue Wang, Joseph Zhou, Edoardo Pedrini, et al.
Journal of Theoretical Biology (2023) Vol. 575, pp. 111645-111645
Open Access | Times Cited: 2
Assessing chemotherapy dosing strategies in a spatial cell culture model
Dhruba Deb, Shu Zhu, Michael J. LeBlanc, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top